Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385492384> ?p ?o ?g. }
- W4385492384 endingPage "5828" @default.
- W4385492384 startingPage "5828" @default.
- W4385492384 abstract "The present study reports the one-step synthesis of several 3-formyl-4-hydroxycouramin-derived enamines (4a-4i) in good yields (65-94%). The characterization of the synthesized compounds was carried out via advanced analytical and spectroscopic techniques, such as melting point, electron impact mass spectrometry (EI-MS), 1H-NMR, 13C-NMR, elemental analysis, FTIR, and UV-Visible spectroscopy. The reaction conditions were optimized, and the maximum yield was obtained at 3-4 h of reflux of the reactants, using 2-butanol as a solvent. The potato disc tumor assay was used to assess Agrobacterium tumefaciens-induced tumors to evaluate the anti-tumor activities of compounds (4a-4i), using Vinblastine as a standard drug. The compound 4g showed the lowest IC50 value (1.12 ± 0.2), which is even better than standard Vinblastine (IC50 7.5 ± 0.6). For further insight into their drug actions, an in silico docking of the compounds was also carried out against the CDK-8 protein. The binding energy values of compounds were found to agree with the experimental results. The compounds 4g and 4h showed the best affinities toward protein, with a binding energy value of -6.8 kcal/mol." @default.
- W4385492384 created "2023-08-03" @default.
- W4385492384 creator A5003014845 @default.
- W4385492384 creator A5004971414 @default.
- W4385492384 creator A5022658621 @default.
- W4385492384 creator A5037298106 @default.
- W4385492384 creator A5040422468 @default.
- W4385492384 creator A5042249946 @default.
- W4385492384 creator A5046830308 @default.
- W4385492384 creator A5067958345 @default.
- W4385492384 creator A5070903355 @default.
- W4385492384 creator A5086720328 @default.
- W4385492384 creator A5090487601 @default.
- W4385492384 date "2023-08-02" @default.
- W4385492384 modified "2023-10-14" @default.
- W4385492384 title "In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor Agents" @default.
- W4385492384 cites W2009019520 @default.
- W4385492384 cites W2028848055 @default.
- W4385492384 cites W2074473216 @default.
- W4385492384 cites W2154792548 @default.
- W4385492384 cites W2159097326 @default.
- W4385492384 cites W2175699244 @default.
- W4385492384 cites W2189238890 @default.
- W4385492384 cites W2285483251 @default.
- W4385492384 cites W2319967173 @default.
- W4385492384 cites W2324080174 @default.
- W4385492384 cites W2398917951 @default.
- W4385492384 cites W2599717252 @default.
- W4385492384 cites W2767396016 @default.
- W4385492384 cites W2900784590 @default.
- W4385492384 cites W2910028065 @default.
- W4385492384 cites W2914653692 @default.
- W4385492384 cites W2951691131 @default.
- W4385492384 cites W2952221086 @default.
- W4385492384 cites W2985356160 @default.
- W4385492384 cites W3020512379 @default.
- W4385492384 cites W3035127458 @default.
- W4385492384 cites W3121381161 @default.
- W4385492384 cites W3140424208 @default.
- W4385492384 cites W3195115757 @default.
- W4385492384 cites W3195865831 @default.
- W4385492384 cites W3214678799 @default.
- W4385492384 cites W4200310641 @default.
- W4385492384 cites W4200450673 @default.
- W4385492384 cites W4205659122 @default.
- W4385492384 cites W4225163236 @default.
- W4385492384 cites W4281621731 @default.
- W4385492384 cites W4282939093 @default.
- W4385492384 cites W4293183434 @default.
- W4385492384 cites W4312296739 @default.
- W4385492384 cites W4313582045 @default.
- W4385492384 cites W4319304236 @default.
- W4385492384 cites W4327600927 @default.
- W4385492384 cites W4367054578 @default.
- W4385492384 cites W4379800031 @default.
- W4385492384 doi "https://doi.org/10.3390/molecules28155828" @default.
- W4385492384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37570800" @default.
- W4385492384 hasPublicationYear "2023" @default.
- W4385492384 type Work @default.
- W4385492384 citedByCount "0" @default.
- W4385492384 crossrefType "journal-article" @default.
- W4385492384 hasAuthorship W4385492384A5003014845 @default.
- W4385492384 hasAuthorship W4385492384A5004971414 @default.
- W4385492384 hasAuthorship W4385492384A5022658621 @default.
- W4385492384 hasAuthorship W4385492384A5037298106 @default.
- W4385492384 hasAuthorship W4385492384A5040422468 @default.
- W4385492384 hasAuthorship W4385492384A5042249946 @default.
- W4385492384 hasAuthorship W4385492384A5046830308 @default.
- W4385492384 hasAuthorship W4385492384A5067958345 @default.
- W4385492384 hasAuthorship W4385492384A5070903355 @default.
- W4385492384 hasAuthorship W4385492384A5086720328 @default.
- W4385492384 hasAuthorship W4385492384A5090487601 @default.
- W4385492384 hasBestOaLocation W43854923841 @default.
- W4385492384 hasConcept C104317684 @default.
- W4385492384 hasConcept C13965031 @default.
- W4385492384 hasConcept C141071460 @default.
- W4385492384 hasConcept C159110408 @default.
- W4385492384 hasConcept C162356407 @default.
- W4385492384 hasConcept C163111631 @default.
- W4385492384 hasConcept C185592680 @default.
- W4385492384 hasConcept C21951064 @default.
- W4385492384 hasConcept C2775905019 @default.
- W4385492384 hasConcept C2776694085 @default.
- W4385492384 hasConcept C2777132456 @default.
- W4385492384 hasConcept C41685203 @default.
- W4385492384 hasConcept C43617362 @default.
- W4385492384 hasConcept C55493867 @default.
- W4385492384 hasConcept C66974803 @default.
- W4385492384 hasConcept C71240020 @default.
- W4385492384 hasConcept C71924100 @default.
- W4385492384 hasConceptScore W4385492384C104317684 @default.
- W4385492384 hasConceptScore W4385492384C13965031 @default.
- W4385492384 hasConceptScore W4385492384C141071460 @default.
- W4385492384 hasConceptScore W4385492384C159110408 @default.
- W4385492384 hasConceptScore W4385492384C162356407 @default.
- W4385492384 hasConceptScore W4385492384C163111631 @default.
- W4385492384 hasConceptScore W4385492384C185592680 @default.
- W4385492384 hasConceptScore W4385492384C21951064 @default.